Search Results - "Neumayer, H. H."

Donor‐Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation by Liefeldt, L., Brakemeier, S., Glander, P., Waiser, J., Lachmann, N., Schönemann, C., Zukunft, B., Illigens, P., Schmidt, D., Wu, K., Rudolph, B., Neumayer, H.‐H., Budde, K.

“…Donor‐specific HLA antibodies (DSA) have a negative impact on kidney graft survival. Therefore, we analyzed the occurrence of DSA and antibody‐mediated…”
Get full text

Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study by Holdaas, H., Fellström, B., Cole, E., Nyberg, G., Olsson, A.G., Pedersen, T.R., Madsen, S., Grönhagen‐Riska, C., Neumayer, H.‐H., Maes, B., Ambühl, P., Hartmann, A., Staffler, B., Jardine, A.G.

“…Renal transplant recipients (RTR) have an increased risk of premature cardiovascular disease. The ALERT study is the first trial to evaluate the effect of…”
Get full text

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection by WAISER, Johannes, BUDDE, Klemens, SCHÜTZ, Manuela, LIEFELDT, Lutz, RUDOLPH, Birgit, SCHÖNEMANN, Constanze, NEUMAYER, Hans-H, LACHMANN, Nils

“…Antibody-mediated rejection (ABMR) following kidney transplantation is associated with poor allograft survival. Conventional treatment based on plasmapheresis…”
Get full text

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study by Slowinski, Torsten, Morgera, Stanislao, Joannidis, Michael, Henneberg, Thomas, Stocker, Reto, Helset, Elin, Andersson, Kirsti, Wehner, Markus, Kozik-Jaromin, Justyna, Brett, Sarah, Hasslacher, Julia, Stover, John F, Peters, Harm, Neumayer, Hans-H, Kindgen-Milles, Detlef

“…Regional citrate anticoagulation (RCA) for continuous renal replacement therapy is widely used in intensive care units (ICUs). However, concern exists about…”
Get full text

Do short courses in evidence based medicine improve knowledge and skills? Validation of Berlin questionnaire and before and after study of courses in evidence based medicine by Fritsche, L, Greenhalgh, T, Falck-Ytter, Y, Neumayer, H-H, Kunz, R

“…Abstract Objective: To develop and validate an instrument for measuring knowledge and skills in evidence based medicine and to investigate whether short…”
Get full text

Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease by Khadzhynov, Dmytro, Wagner, Frank, Formella, Stephan, Wiegert, Erol, Moschetti, Viktoria, Slowinski, Torsten, Neumayer, Hans-H, Liesenfeld, Karl-Heinz, Lehr, Thorsten, Härtter, Sebastian, Friedman, Jeffrey, Peters, Harm, Clemens, Andreas

“…Dabigatran, a specific, reversible direct thrombin inhibitor, is used to prevent ischaemic and haemorrhagic strokes in patients with atrial fibrillation. As…”
Get more information

Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein by Mathia, S., Paliege, A., Koesters, R., Peters, H., Neumayer, H.-H., Bachmann, S., Rosenberger, C.

“…Aim Von Hippel‐Lindau protein (VHL) provides the degradation of hypoxia‐inducible factor (HIF). Tetracycline‐induced, Pax8‐rtTA‐based knockout of VHL (VHL‐KO)…”
Get full text

Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification by Braun, J, Asmus, H G, Holzer, H, Brunkhorst, R, Krause, R, Schulz, W, Neumayer, H-H, Raggi, P, Bommer, J

“…Calcium carbonate used as a phosphate binder may contribute to cardiovascular calcification. Long-term comparisons of sevelamer, a non-calcium polymeric…”
Get more information

Pharmacokinetic and Pharmacodynamic Comparison of Enteric‐Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients by Budde, K., Bauer, S., Hambach, P., Hahn, U., Röblitz, H., Mai, I., Diekmann, F., Neumayer, H.‐H., Glander, P.

“…The aim of this single‐center crossover substudy was to assess pharmacokinetics and pharmacodynamics [inosine 5′‐monophosphate dehydrogenase (IMPDH) activity]…”
Get full text

Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation by Khadzhynov, Dmytro, MD, Schelter, Christin, Lieker, Ina, MD, Mika, Alice, Staeck, Oliver, MD, Neumayer, Hans.-H., MD, Peters, Harm, MD, Slowinski, Torsten, MD

“…Abstract Background Systemic citrate accumulation is a complication of regional citrate anticoagulation (RCA) during continuous renal replacement therapy…”
Get full text

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation by Lowance, David, Neumayer, Hans-H, Legendre, Christophe M, Squifflet, Jean-Paul, Kovarik, Josef, Brennan, Patrick J, Norman, Douglas, Mendez, Rafael, Keating, Michael R, Coggon, Gary L, Crisp, Adam, Lee, Ira C

“…Cytomegalovirus (CMV) is the leading cause of infectious complications after organ transplantation and has been implicated as a cause of graft rejection. In…”
Get full text

Inosine 5′-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients by Glander, Petra, Waiser, Johannes, Hambach, Pia, Bachmann, Friederike, Budde, Klemens, Eckardt, Kai-Uwe, Friedersdorff, Frank, Gaedeke, Jens, Kron, Susanne, Lorkowski, Christine, Mai, Marco, Neumayer, Hans-H., Peters, Robert, Rudolph, Birgit, Schmidt, Danilo, Wu, Kaiyin, Liefeldt, Lutz

“…BACKGROUND.Mycophenolic acid (MPA) is a standard immunosuppressant in organ transplantation. A simple monitoring biomarker for MPA treatment has not been…”
Get full text

Volume matters: CT-based renal cortex volume measurement in the evaluation of living kidney donors by Halleck, Fabian, Diederichs, Gerd, Koehlitz, Torsten, Slowinski, Torsten, Engelken, Florian, Liefeldt, Lutz, Friedersdorff, Frank, Fuller, T Florian, Magheli, Ahmed, Neumayer, Hans-H, Budde, Klemens, Waiser, Johannes

“…Currently, no international standard for the pre-transplant evaluation of living donor renal function exists. Following a standardized questionnaire on current…”
Get more information

Predictors of Success in Conversion from Calcineurin Inhibitor to Sirolimus in Chronic Allograft Dysfunction by Diekmann, Fritz, Budde, Klemens, Oppenheimer, Federico, Fritsche, Lutz, Neumayer, Hans H., Campistol, Josep M.

“…Chronic allograft dysfunction (CAD) is a major cause of graft loss in long‐term kidney transplant recipients. To identify predictors of successful conversion…”
Get full text

Increased Incidence of Angioedema with ACE Inhibitors in Combination with mTOR Inhibitors in Kidney Transplant Recipients by Duerr, Michael, Glander, Petra, Diekmann, Fritz, Dragun, Duska, Neumayer, Hans-H, Budde, Klemens

“…The clinical manifestation of angioedema ranges from minor facial edema up to life-threatening swelling of mouth and throat. Hereditary defects, drugs, and…”
Get full text

Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardiovascular Complications in Renal Transplantation by Fellström, B., Jardine, A. G., Soveri, I., Cole, E., Neumayer, H.‐H., Maes, B., Gimpelewicz, C., Holdaas, H.

“…Renal transplant recipients (RTR) have shortened life expectancy, primarily due to premature cardiovascular disease (CVD). Traditional CVD risk factors are…”
Get full text

Identification of T Cell–Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood by Matz, Mareen, Fabritius, Katharina, Lorkowski, Christine, Dürr, Michael, Gaedeke, Jens, Durek, Pawel, Grün, Joachim R, Goestemeyer, Anne, Bachmann, Friederike, Wu, Kaiyin, Rudolph, Birgit, Schmidt, Danilo, Weber, Ulrike, Haftmann, Claudia, Unterwalder, Nadine, Lachmann, Nils, Radbruch, Andreas, Neumayer, Hans-H, Mashreghi, Mir-Farzin, Budde, Klemens

“…BACKGROUNDMicroRNAs (miRNAs, miR) hold important roles in the posttranscriptional regulation of gene expression. Their function has been correlated with kidney…”
Get full text

Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells by Brun, Juliane, Lutz, Katrin A, Neumayer, Katharina M H, Klein, Gerd, Seeger, Tanja, Uynuk-Ool, Tatiana, Wörgötter, Katharina, Schmid, Sandra, Kraushaar, Udo, Guenther, Elke, Rolauffs, Bernd, Aicher, Wilhelm K, Hart, Melanie L

“…The use of mesenchymal stromal cells (MSCs) differentiated toward a smooth muscle cell (SMC) phenotype may provide an alternative for investigators interested…”
Get full text

Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression by Trappe, R., Hinrichs, C., Appel, U., Babel, N., Reinke, P., Neumayer, H.‐H., Budde, K., Dreyling, M., Dührsen, U., Kliem, V., Schüttrumpf, S., Hauser, I. A., Mergenthaler, H.‐G., Schlattmann, P., Anagnostopoulos, I., Doerken, B., Riess, H.

“…We addressed the effect of post‐transplant lymphoproliferative disorder (PTLD) treatment with rituximab monotherapy or CHOP‐based chemotherapy (± rituximab)…”
Get full text

Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure by Morgera, Stanislao, Haase, Michael, Kuss, Thomas, Vargas-Hein, Ortrud, Zuckermann-Becker, Heidrun, Melzer, Christoph, Krieg, Hanno, Wegner, Brigitte, Bellomo, Rinaldo, Neumayer, Hans-H

“…OBJECTIVE:High cutoff hemofilters are characterized by an increased effective pore size designed to facilitate the elimination of inflammatory mediators in…”
Get full text